200 related articles for article (PubMed ID: 29133241)
1. In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line.
Morsy MA; El-Sheikh AAK; Ibrahim ARN; Khedr MA; Al-Taher AY
Eur J Pharm Sci; 2018 Jan; 112():87-94. PubMed ID: 29133241
[TBL] [Abstract][Full Text] [Related]
2. Capsaicin and Piperine Can Overcome Multidrug Resistance in Cancer Cells to Doxorubicin.
Li H; Krstin S; Wang S; Wink M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498663
[TBL] [Abstract][Full Text] [Related]
3. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells.
Li S; Lei Y; Jia Y; Li N; Wink M; Ma Y
Phytomedicine; 2011 Dec; 19(1):83-7. PubMed ID: 21802927
[TBL] [Abstract][Full Text] [Related]
4. Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors.
Syed SB; Lin SY; Arya H; Fu IH; Yeh TK; Charles MRC; Periyasamy L; Hsieh HP; Coumar MS
Chem Biol Drug Des; 2021 Jan; 97(1):51-66. PubMed ID: 32633857
[TBL] [Abstract][Full Text] [Related]
5. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment.
Katiyar SS; Muntimadugu E; Rafeeqi TA; Domb AJ; Khan W
Drug Deliv; 2016 Sep; 23(7):2608-2616. PubMed ID: 26036652
[TBL] [Abstract][Full Text] [Related]
7. Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.
Syed SB; Arya H; Fu IH; Yeh TK; Periyasamy L; Hsieh HP; Coumar MS
Sci Rep; 2017 Aug; 7(1):7972. PubMed ID: 28801675
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells.
Maimaitijiang A; Wang B; Yang H; Tang D; Liu Y; Aisa HA
Eur J Med Chem; 2022 Dec; 244():114822. PubMed ID: 36242992
[TBL] [Abstract][Full Text] [Related]
9. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic.
Ma B; Chai S; Li N; To KK; Kan WL; Yang D; Lin G
Int J Pharm; 2012 Mar; 424(1-2):33-9. PubMed ID: 22226881
[TBL] [Abstract][Full Text] [Related]
10. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
11. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
13. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
[TBL] [Abstract][Full Text] [Related]
14. The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers.
Bedada SK; Boga PK
Eur J Clin Pharmacol; 2017 Mar; 73(3):343-349. PubMed ID: 27981349
[TBL] [Abstract][Full Text] [Related]
15. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
Bidwell GL; Davis AN; Fokt I; Priebe W; Raucher D
Invest New Drugs; 2007 Aug; 25(4):313-26. PubMed ID: 17483874
[TBL] [Abstract][Full Text] [Related]
16. A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors.
Singh DV; Godbole MM; Misra K
J Mol Model; 2013 Jan; 19(1):227-38. PubMed ID: 22864626
[TBL] [Abstract][Full Text] [Related]
17. Piperine attenuates UV-R induced cell damage in human keratinocytes via NF-kB, Bax/Bcl-2 pathway: An application for photoprotection.
Verma A; Kushwaha HN; Srivastava AK; Srivastava S; Jamal N; Srivastava K; Ray RS
J Photochem Photobiol B; 2017 Jul; 172():139-148. PubMed ID: 28550736
[TBL] [Abstract][Full Text] [Related]
18. Interaction of CJZ3, a lomerizine derivative, with ATPase activity of human P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Ji BS; Li M; He L
Pharmazie; 2010 Jul; 65(7):515-9. PubMed ID: 20662321
[TBL] [Abstract][Full Text] [Related]
19. Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P-gp-overexpressing MCF-7 cells.
Shafiei-Irannejad V; Samadi N; Yousefi B; Salehi R; Velaei K; Zarghami N
Chem Biol Drug Des; 2018 Jan; 91(1):269-276. PubMed ID: 28782285
[TBL] [Abstract][Full Text] [Related]
20. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway.
Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK
Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
